Arlene A. Obias

460 total citations
8 papers, 377 citations indexed

About

Arlene A. Obias is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Arlene A. Obias has authored 8 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Infectious Diseases and 2 papers in Clinical Biochemistry. Recurrent topics in Arlene A. Obias's work include Antifungal resistance and susceptibility (3 papers), Urinary Tract Infections Management (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Arlene A. Obias is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Urinary Tract Infections Management (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Arlene A. Obias collaborates with scholars based in United States. Arlene A. Obias's co-authors include Gary A. Noskin, Teresa Zembower, Sandra Reiner, Jie Huang, Pavani Reddy, Chao Qi, Marc H. Scheetz, John R. Warren, Lance R. Peterson and Michael Postelnick and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Arlene A. Obias

8 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arlene A. Obias United States	7	216	151	144	76	73	8	377
Mel DeCorby Canada	8	216 1.0×	130 0.9×	130 0.9×	90 1.2×	115 1.6×	11	412
C. J. Henwood United Kingdom	7	281 1.3×	110 0.7×	164 1.1×	113 1.5×	70 1.0×	7	462
Ergina Malli Greece	11	202 0.9×	86 0.6×	98 0.7×	62 0.8×	71 1.0×	15	317
Silvana Vargas Superti Brazil	11	256 1.2×	156 1.0×	118 0.8×	88 1.2×	53 0.7×	20	437
Fawzia Alotaibi Saudi Arabia	11	146 0.7×	120 0.8×	103 0.7×	81 1.1×	83 1.1×	18	339
Yaning Mei China	14	196 0.9×	129 0.9×	105 0.7×	54 0.7×	52 0.7×	28	434
C. Cattoën France	11	274 1.3×	119 0.8×	81 0.6×	76 1.0×	54 0.7×	32	435
Xiu-li Xie China	6	242 1.1×	128 0.8×	74 0.5×	100 1.3×	125 1.7×	14	351
Lily Siew Yong Ng Singapore	13	295 1.4×	121 0.8×	127 0.9×	104 1.4×	49 0.7×	22	479
G. Marcadé France	9	291 1.3×	119 0.8×	105 0.7×	48 0.6×	56 0.8×	11	382

Countries citing papers authored by Arlene A. Obias

Since Specialization

Citations

This map shows the geographic impact of Arlene A. Obias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlene A. Obias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlene A. Obias more than expected).

Fields of papers citing papers by Arlene A. Obias

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arlene A. Obias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlene A. Obias. The network helps show where Arlene A. Obias may publish in the future.

Co-authorship network of co-authors of Arlene A. Obias

This figure shows the co-authorship network connecting the top 25 collaborators of Arlene A. Obias. A scholar is included among the top collaborators of Arlene A. Obias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlene A. Obias. Arlene A. Obias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Reddy, Pavani, Arlene A. Obias, Sandra Reiner, et al.. (2008). Reply to Blot et al. Clinical Infectious Diseases. 46(3). 482–482. 1 indexed citations

Scheetz, Marc H., Chao Qi, John R. Warren, et al.. (2007). In Vitro Activities of Various Antimicrobials Alone and in Combination with Tigecycline against Carbapenem-Intermediate or -Resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 51(5). 1621–1626. 86 indexed citations

Reddy, Pavani, Arlene A. Obias, Sandra Reiner, et al.. (2007). Screening for Extended-Spectrum -Lactamase-Producing Enterobacteriaceae among High-Risk Patients and Rates of Subsequent Bacteremia. Clinical Infectious Diseases. 45(7). 846–852. 145 indexed citations

Qi, Chao, Xiaotian Zheng, Arlene A. Obias, et al.. (2006). Comparison of Testing Methods for Detection of Decreased Linezolid Susceptibility Due to G2576T Mutation of the 23S rRNA Gene in Enterococcus faecium and Enterococcus faecalis. Journal of Clinical Microbiology. 44(3). 1098–1100. 23 indexed citations

Gavin, Patrick J., Jim Warren, Arlene A. Obias, Stephen M. Collins, & Lance R. Peterson. (2002). Evaluation of the Vitek 2 System for Rapid Identification of Clinical Isolates of Gram-Negative Bacilli and Members of the Family Streptococcaceae. European Journal of Clinical Microbiology & Infectious Diseases. 21(12). 869–874. 29 indexed citations

Obias, Arlene A., et al.. (2000). Activity of voriconazole against Candida albicans and Candida krusei isolated since 1984☆. International Journal of Antimicrobial Agents. 16(3). 205–209. 6 indexed citations

Obias, Arlene A., et al.. (1998). Thirteen-Year Evolution of Azole Resistance in Yeast Isolates and Prevalence of Resistant Strains Carried by Cancer Patients at a Large Medical Center. Antimicrobial Agents and Chemotherapy. 42(4). 734–738. 62 indexed citations

Noskin, Gary A., et al.. (1997). Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicans. Journal of Clinical Microbiology. 35(6). 1473–1476. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact